The Continuous Bioprocessing Market encompasses the industry dedicated to the development and implementation of continuous flow technologies for biologics production. This market includes equipment, software, and services that streamline bioprocessing operations, enhancing efficiency, scalability, and cost-effectiveness. It supports pharmaceutical and biotechnology sectors by facilitating the production of monoclonal antibodies, vaccines, and other biologics, driving innovation in drug development and manufacturing.